Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma

OBJECTIVES: To determine the safety of Puquitinib Mesylate (XC-302), an oral inhibitor of phosphatidylinositol 3-kinase, in treating relapsed or refractory non-Hodgkin's lymphoma (NHL). METHODS: Between October 2013 and July 2015, 21 patients from Sun Yat-sen University Cancer Center were treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hang, Wang, Yu, Zhan, Jing, Xia, Yi, Sun, Peng, Bi, Xi-Wen, Liu, Pan-Pan, Li, Zhi-Ming, Li, Su, Zou, Ben-Yan, Jiang, Wen-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791286/
https://www.ncbi.nlm.nih.gov/pubmed/26510909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791286/
https://www.ncbi.nlm.nih.gov/pubmed/26510909

Ejemplares similares